DYADIC INTERNATIONAL INC Investments and Cash
DYADIC INTERNATIONAL INC (DYAI) had Investments and Cash of $3.22 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets
us-gaap:InvestmentsAndCash · last filed 2026-08-12
- 2026-06-30: Investments and Cash $3.22M.
- 2026-03-31: Investments and Cash $5.68M.
- 2025-12-31: Investments and Cash $7.32M.
- 2025-09-30: Investments and Cash $9.00M.
| Period end | Investments and Cash | Investments and Cash as first filed |
|---|---|---|
| 2026-06-30 | $3.22M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $5.68M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $7.32M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $9.00M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $5.39M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $7.35M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $9.26M 10-Q · filed 2025-05-14 | |
| 2024-09-30 | $9.92M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $10.10M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $12.04M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $7.26M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $8.18M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $10.13M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $11.74M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $12.64M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $14.20M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $15.64M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $17.44B 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $20.26M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $22.75M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $25.60M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $27.23M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $29.09M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $30.47M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $31.93M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $33.67M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $35.73M 10-K · filed 2021-03-30 | $35.74M 10-K · filed 2020-03-30 |
| 2019-09-30 | $36.98M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $38.42M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $39.75M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $41.12M 10-K · filed 2020-03-30 | |
| 2017-12-31 | $48.51M 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |